“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”

[1]  M. Masternak,et al.  Role of BAG5 in Protein Quality Control: Double-Edged Sword? , 2022, Frontiers in Aging.

[2]  Jeffrey R. Whiteaker,et al.  Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer , 2021, Cell reports. Medicine.

[3]  Liang Zhao,et al.  CCT8 recovers WTp53-suppressed cell cycle evolution and EMT to promote colorectal cancer progression , 2021, Oncogenesis.

[4]  Sara R. Savage,et al.  A highly annotated database of genes associated with platinum resistance in cancer , 2021, Oncogene.

[5]  J. Rubinstein,et al.  Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthase , 2021, Nature Chemical Biology.

[6]  I. Chirivella,et al.  Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study , 2021, British Journal of Cancer.

[7]  S. Vagner,et al.  The plasticity of mRNA translation during cancer progression and therapy resistance , 2021, Nature Reviews Cancer.

[8]  Hui Sun,et al.  Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer , 2021, Frontiers in Genetics.

[9]  E. Cuppen,et al.  Prospective experimental treatment of colorectal cancer patients based on organoid drug responses , 2021, ESMO open.

[10]  Shengtao Lin,et al.  Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin , 2021, Aging.

[11]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[12]  Yun-Shien Lee,et al.  Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma. , 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

[13]  J. Shim,et al.  Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression , 2020, Oncogene.

[14]  An-zheng Nie,et al.  Roles of Aminoacyl-tRNA Synthetases in Cancer , 2020, Frontiers in Cell and Developmental Biology.

[15]  Fang Yang,et al.  c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis , 2020, Cell Death & Disease.

[16]  R. Labianca,et al.  Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  Bao Sun,et al.  Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer , 2020, Cell Death & Disease.

[18]  O. Coqueret,et al.  tRNA biogenesis and specific aminoacyl-tRNA synthetases regulate senescence stability under the control of mTOR , 2020, bioRxiv.

[19]  R. Lothe,et al.  Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity , 2020, Clinical Cancer Research.

[20]  A. Cervantes,et al.  Personalized Medicine: Recent Progress in Cancer Therapy , 2020, Cancers.

[21]  L. Ricci-Vitiani,et al.  c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors , 2020, Cancers.

[22]  W. V. van Gulik,et al.  Differential proteomic analysis by SWATH-MS unravels the most dominant mechanisms underlying yeast adaptation to non-optimal temperatures under anaerobic conditions , 2020, Scientific Reports.

[23]  Kat S. Moore,et al.  Pancreatic cancer organoids recapitulate disease and allow personalized drug screening , 2019, Proceedings of the National Academy of Sciences.

[24]  B. Haibe-Kains,et al.  Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer , 2019, Clinical Cancer Research.

[25]  E. Cuppen,et al.  Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients , 2019, Science Translational Medicine.

[26]  Anthony J. Cesnik,et al.  Comprehensive in vivo identification of the c-Myc mRNA protein interactome using HyPR-MS , 2019, RNA.

[27]  Li‐yu Lee,et al.  Palbociclib Promotes Dephosphorylation of NPM/B23 at Threonine 199 and Inhibits Endometrial Cancer Cell Growth , 2019, Cancers.

[28]  S. Kannan,et al.  Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method , 2019, Journal of Translational Medicine.

[29]  Qiaojun He,et al.  Identification of PRDX6 as a regulator of ferroptosis , 2019, Acta Pharmacologica Sinica.

[30]  Pixu Liu,et al.  MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer , 2019, EBioMedicine.

[31]  Do Young Hyeon,et al.  Evolution of the multi-tRNA synthetase complex and its role in cancer , 2019, The Journal of Biological Chemistry.

[32]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[33]  Jan Gorodkin,et al.  Cytoscape stringApp: Network analysis and visualization of proteomics data , 2018, bioRxiv.

[34]  Li Liu,et al.  The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma. , 2019, International journal of clinical and experimental pathology.

[35]  Seung Ah Lee,et al.  Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review , 2019, International journal of cancer.

[36]  Hans Clevers,et al.  A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening. , 2018, Cell stem cell.

[37]  A. Cervantes,et al.  NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer , 2018, Clinical Cancer Research.

[38]  M. Matúšková,et al.  ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells , 2018, BMC Cancer.

[39]  V. Prasad,et al.  Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology , 2018, JAMA oncology.

[40]  Hayley E. Francies,et al.  Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics , 2018, Nature Communications.

[41]  Robert E Denroche,et al.  Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. , 2018, Cancer discovery.

[42]  E. Prochownik,et al.  The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues , 2018, Front. Endocrinol..

[43]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[44]  Andrea Sottoriva,et al.  Patient-derived organoids model treatment response of metastatic gastrointestinal cancers , 2018, Science.

[45]  Hans Clevers,et al.  A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity , 2018, Cell.

[46]  N. Socci,et al.  Accelerating Discovery of Functional Mutant Alleles in Cancer. , 2018, Cancer discovery.

[47]  Zhitu Zhu,et al.  Transforming growth factor-β1 contributes to oxaliplatin resistance in colorectal cancer via epithelial to mesenchymal transition , 2017, Oncology letters.

[48]  Hans Clevers,et al.  Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer. , 2017, Cell reports.

[49]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[50]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[51]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[52]  M. Robinson,et al.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences , 2015, F1000Research.

[53]  M. Robinson,et al.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. , 2015, F1000Research.

[54]  Hayley E. Francies,et al.  Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.

[55]  G. Inghirami,et al.  Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.

[56]  M. Spector,et al.  Organoid Models of Human and Mouse Ductal Pancreatic Cancer , 2015, Cell.

[57]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[58]  Hans Clevers,et al.  Organoid Cultures Derived from Patients with Advanced Prostate Cancer , 2014, Cell.

[59]  F. Stricher,et al.  HSPA8/HSC70 chaperone protein , 2013, Autophagy.

[60]  R. Pal,et al.  Send Orders of Reprints at Reprints@benthamscience.net Integrated Analysis of Transcriptomic and Proteomic Data , 2022 .

[61]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[62]  Helmut Klocker,et al.  Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis , 2013, BMC Cancer.

[63]  A. Wilm,et al.  LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets , 2012, Nucleic acids research.

[64]  J. Bartek,et al.  Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage , 2012, Cell cycle.

[65]  Heng Li,et al.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data , 2011, Bioinform..

[66]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[67]  Chia Huey Ooi,et al.  Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. , 2011, Gastroenterology.

[68]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[69]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[70]  David N. Boone,et al.  Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation , 2008, Proceedings of the National Academy of Sciences.

[71]  L. Terracciano,et al.  Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status , 2008, Modern Pathology.

[72]  S. Elledge,et al.  Non-Oncogene Addiction and the Stress Phenotype of Cancer Cells , 2007, Cell.

[73]  Yan Chen,et al.  Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction , 2004, Oncogene.

[74]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[75]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..